Latest Peptide News

Peptide News — page 4

A detailed shot of white capsules in a black bowl, highlighting healthcare concerns. — Glass multi-dose injection vial on a clinical counter with a pharmacy label showing a lot number

August 6, 2026

Compounded Glutathione Recall Over Elevated Endotoxin Levels

An Austin, Texas compounding pharmacy has pulled specified lots of an injectable antioxidant preparation after its own testing flagged a contaminant that sterility testing does not catch. The compounded glutathione recall reaches the patient level, which means vials already dispensed to individuals are covered.

Compounding & SupplySafety & Regulation

How this page is made. PeptideWiz News covers regulatory actions, published research, and industry developments from a fixed list of primary sources — the FDA, NIH, EMA, ClinicalTrials.gov, PubMed, peer-reviewed journals, and company press rooms. Articles are drafted with AI assistance from those sources, reviewed before publication, and always link to the original. Read the full editorial standards & corrections policy. This is journalism about peptides, not medical advice: it does not recommend any substance, does not state dosages, and is not a substitute for your provider.

Latest Peptide News

Peptide News — page 4

Compounded Glutathione Recall Over Elevated Endotoxin Levels

The peptide news that mattered, weekly